Solitary hepatic lymphangioma mimicking liver malignancy: A case report and literature review
作者机构:Hepatic Surgery CenterTongji HospitalTongji Medical CollegeHuazhong University of Science and TechnologyWuhan 430030Hubei ProvinceChina Endoscopic UnitDepartment of Gastroenterology and HepatologyTongji HospitalTongji Medical CollegeHuazhong University of Science and TechnologyWuhan 430030Hubei ProvinceChina
出 版 物:《World Journal of Clinical Cases》 (世界临床病例杂志)
年 卷 期:2020年第8卷第19期
页 面:4633-4643页
核心收录:
学科分类:1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学]
主 题:Hepatic lymphangioma Hepatocellular carcinoma Laparoscopic hepatectomy Trans-arterial chemoembolization Adult Case report
摘 要:BACKGROUND Hepatic lymphangioma,a malformation of the liver lymphatic system,is a rare benign neoplasm and usually coexists with other visceral *** hepatic lymphangioma is much more rarely seen and could cause a clinical misinterpretation as *** SUMMARY A 50-year-old woman with a liver mass of approximately 3.5 cm was initially diagnosed with hepatocellular carcinoma given the risk factors for liver cancer that she presented with,including Schistosome japonicum infection and jaundice,and also together with imaging results,which showed the mass enhanced quickly in the arterial phase and faded fast in the venous *** patient did not have the surgery first but received three rounds of transarterial chemoembolization because of her anxiety and fears for ***,the patient underwent laparoscopic liver segment 4b resection and cholecystectomy and was discharged from the hospital only 10 d after the *** pathological examination indicated the mass as hepatic *** patient has been followed up for 30 mo without *** raise the awareness of this misdiagnosed case and to better diagnose and treat this rare disease in future,we reviewed the published literature of solitary hepatic lymphangioma for its clinical symptoms,imaging presentation,operative techniques,histology features and *** Solitary hepatic lymphangioma mimicking malignancy makes diagnosis *** surgical resection is the first choice to treat solitary hepatic lymphangioma.